Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Onconetix, Inc.ONCO · Entity 8471 | Director | September 26, 2024 | September 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Onconetix, Inc.
Report date September 26, 2024 · Filed September 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,396 |
Reported balance
After 2024-09-26 transaction · row 1
1 source rowRow 1 · 2024-09-26 · Grant · Acquired 3,318 · Balance 3,396 F1: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2024 Filed Sep 30, 2024 19:11 UTC | Onconetix, Inc. ONCO · Entity 8471 | GrantCommon Stock | 3,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-083523 · ownership.xml · nonDerivative · entry 1 SINGH AJIT · CIK 0001590946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,396 F1 · shares: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 16:05 UTC | Onconetix, Inc. ONCO · Entity 8471 | GrantCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-015752 · ownership.xml · nonDerivative · entry 1 SINGH AJIT · CIK 0001590946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,125 F1 · shares: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on June 14, 2024, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.